◆ 会议时间:2022年10月15日至19日
◆ 会议地点:西班牙 巴塞罗那(Barcelona, Spain)
◆ 会议简介:
2022年第35届欧洲核医学协会(EANM)年会将于2022年10月15日至19日在西班牙巴塞罗那举行。EANM年会是全球最具价值的核医学会议,每年都会吸引6,000多名来自世界各地的相关专业人士参会。
欧洲核医学协会(EANM)成立于1985年,是欧洲最大的非营利性核医学组织。EANM的愿景是优化和推进核医学的科学和教育,以造福于人类。EANM的目标是成为一个传播和讨论核医学领域的最新成果,包括多模态成像和相关主题的平台。EANM在欧洲41个国家拥有9,000多名会员,包括医师、科学家、技术人员以及从事核医学或宣相关领域工作的其他人员等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com).
EANM 2022 - 35th Annual Congress of the European Association of Nuclear Medicine
Date: October 15 – 19, 2022
Venue: CCIB – Barcelona International Convention Centre - Barcelona, Spain
摘要征集:
The extended submission deadline is Wednesday, May 4, 2022 – 23:59 CEST.
Notification of Abstract Acceptance:
Authors will be notified about the acceptance of abstracts by email on June 21, 2022.
Withdrawal of Abstracts:
Abstracts can only be withdrawn in writing (abstracts@eanm.org) until July 1, 2022.
点此提交摘要>>>Submit Abstract>>>
摘要提交指南/ABSTRACT SUBMISSION GUIDELINE
Dear Colleagues,
On behalf of the European Association of Nuclear Medicine, it is my great honour to invite you to the 35th Annual EANM Congress. The event will finally be held in person from October 15-19, 2022 in Barcelona, Spain. After two years of virtual events, we are now confident of hosting the Congress in its usual and much missed format.
The last two years have been truly challenging for the entire world due to the pandemic. This has been especially true for those who work in healthcare, as we all do. Nevertheless, nuclear medicine has experienced incredible growth, both in diagnostic imaging and therapy. We have seen exciting innovations in every area of our specialist field: new whole-body PET tomographs are now being used clinically, PSMA tracers have been incorporated into clinical guidelines, and excellent trials of theranostic radiopharmaceuticals were presented and published. Furthermore, many other new radiopharmaceuticals which facilitate the study and treatment of new targets are being introduced, with more and more protocols addressing unmet clinical needs and new applications in operation. This success remains related to that very peculiar characteristic of our specialist field, namely, its functional approach to medicine, and we really feel the need to celebrate all such achievements and innovations with a real congress as we used to do.
We proudly celebrated the status of the EANM Congress as the world’s leading meeting for nuclear medicine when we reached almost 7000 participants in 2019. The pandemic subsequently forced us to move to a virtual format for two consecutive years and we did our best to keep a great event running with all the best features of an EANM Congress. We succeeded in introducing many innovative features and we were able to maintain a great scientific programme as well as some entertaining sessions. However, it is clear to everybody that the ‘in-person’ Congress was missed very much and that the opportunities to interact and network were not comparable. As a result, we are happy to announce that we will come back to the usual format this year at one of our favourite venues, Barcelona. On the other hand, we have also learned that a virtual event does have some advantages, above all, the opportunity to allow many colleagues to attend sessions that they otherwise would probably not have seen. For this reason, we will also plan a virtual event for summer 2022 for the first time: The EANM Multidisciplinary Days on June 28-30, 2022. Therefore, sessions like the former Pre-Congress Symposia and most Joint Symposia will run virtually in June, making it easier for everybody to attend, while the majority of sessions will take place in person in October. Here we are certain to focus on opportunities to meet other professionals in the field and the social aspect of the Congress.
In summary, we are planning a great live event for October and an additional virtual event in June. We are working to provide you with a congress filled with superb and comprehensive scientific content as well as a lot of other innovative features to make your participation truly memorable.
Stefano Fanti
EANM Congress Chair 2020–2022
EANM2022 注册费:
EANM’22 Congress Registration Fees
Registration Fee in Euro
|
Early registration
until June 30, 2022 |
Advanced registration
until October 05, 2022 |
Late registration
after October 05, 2022 |
Main Congress Ticket |
|
|
|
EANM Member3) |
350,- |
500,- |
650,- |
Non-Member |
700,- |
850,- |
950,- |
EANM Junior Member1) 3) |
200,- |
350,- |
500,- |
Junior Non-Member1) |
375,- |
475,- |
575,- |
EANM Nurse/Technologist Member3) |
150,- |
250,- |
350,- |
Nurse/Technologist Non-Member2) |
275,- |
375,- |
475,- |
EANM Associate Member3) |
350,- |
500,- |
650,- |
Associate Non-Member |
700,- |
850,- |
950,- |
Student4) |
0,- |
0,- |
0,- |
1) Physician or other scientist in training, up to the age of 38 (maximum age on November 1, 2022). For Junior Non-Members: confirmation letter (in English) incl. signature of Head of Department and copy of passport showing date of birth are indispensable for proof of status.
2) Nurse, healthcare technologist or laboratory technologist, being employed in a respective current professional occupation. Confirmation letter (in English) incl. signature of Head of Department is indispensable for proof of status.
3) Only members who have paid the full amount of their membership fee for the year 2022 by May 31, 2022 will benefit from the reduced “Member” registration fee. Members who have paid their membership fee for the year 2022 after May 31, 2022 will be charged the Non-Member fee.
4) Student without any academic degree, up to the age of 26 (maximum age on November 1, 2022), even if a degree has been achieved in a completely different field and/or has no relevance to the current professional occupation. Confirmation letter (in English) incl. signature of Head of Department and copy of passport showing date of birth are indispensable for proof of status. Students already holding an academic degree (and not older than 38 years of age on November 1, 2022) must register as Juniors!
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|